NCT02966704

Brief Summary

The evaluation of protein quality has been identified as the top priority question by the Food and Agricultural Organization (FAO) of the United Nations. However, the current available methods do not precisely estimate protein quality, or need invasive procedures. The proposed 'dual tracer approach' is a non-invasive method to evaluate protein quality in humans. The present project characterizes the use of 15N-intrinsically-labelled milk protein as a reference-protein for development a non-invasive method that can be used to assess protein quality in human subjects

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2016

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 8, 2016

Completed
7 months until next milestone

Study Start

First participant enrolled

July 21, 2016

Completed
4 months until next milestone

First Posted

Study publicly available on registry

November 17, 2016

Completed
4 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 21, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 21, 2016

Completed
Last Updated

December 14, 2017

Status Verified

December 1, 2017

Enrollment Period

4 months

First QC Date

January 8, 2016

Last Update Submit

December 13, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • ratio of isotopic enrichment

    6 hours

Study Arms (2)

meal 1

EXPERIMENTAL

mixed meal with high level of intrinsically labeled milk protein

Dietary Supplement: intrinsically labeled milk protein

meal 2

EXPERIMENTAL

mixed meal with low level of intrinsically labeled milk protein

Dietary Supplement: intrinsically labeled milk protein

Interventions

meal 1meal 2

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy
  • Age: 20 - 35 y
  • BMI: 18.5 - 25 kg/m2
  • Stable dietary habits
  • Veins suitable for cannulation (blood sampling)

You may not qualify if:

  • Having a history of medical or surgical events that may significantly affect the study outcome
  • Medical drug use accept incidental use of paracetamol
  • (Chronic) disease which might influence the study outcomes e.g. diabetes mellitus or any other endocrine disorder, active cardiovascular disease, hepatic disease, renal disease, cancer
  • Milk protein intolerance
  • Alcohol consumption of \>14 (women) or \> 21 (men) units per week
  • Drug abuse
  • Moderate intense physical activity (exercise) for more than 5 hours/week
  • Reported weight loss or weight gain of \> 3 kg in the month prior to pre-study screening
  • Reported slimming diet, or medically prescribed diet
  • Having a habitual diet with a protein content of \<10 En% \> 30 En%
  • Reported vegan or macrobiotic life-style
  • Recent blood donation (\<1 month prior to Day 01 of the study)
  • Not willing to comply to the controlled dietary intervention guidelines
  • Not willing or afraid to give up blood donation during the study
  • Personnel of Wageningen University, department of Human Nutrition, their partner and their first and second degree relatives
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • van der Wielen N, Khodorova NV, Gerrits WJJ, Gaudichon C, Calvez J, Tome D, Mensink M. Blood 15N:13C Enrichment Ratios Are Proportional to the Ingested Quantity of Protein with the Dual-Tracer Approach for Determining Amino Acid Bioavailability in Humans. J Nutr. 2020 Sep 1;150(9):2346-2352. doi: 10.1093/jn/nxaa205.

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 8, 2016

First Posted

November 17, 2016

Study Start

July 21, 2016

Primary Completion

November 21, 2016

Study Completion

November 21, 2016

Last Updated

December 14, 2017

Record last verified: 2017-12